FolioLanternBeta
EWTXEdgewise Therapeutics, Inc.

Joanne Donovan

CMO at Edgewise Therapeutics, Inc., as of Aug 17, 2026Sold $4.6M of stock in the past 12 months: 94% under a disclosed plan and 6% to cover taxes.

Updated Oct 16, 2026 from SEC filings · covers Oct 17, 2025 to Oct 16, 2026
131K
shares sold, past 12 months
7
days with sales
$1.9M
largest single day, May 5, 2026
1
company filed for

Share of stake sold and shares held at Edgewise Therapeutics, Inc. are being verified and not shown yet. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMar 2026: $1.2M under a disclosed planMarApr 2026: $926K under a disclosed planAprMay 2026: $2.1M under a disclosed plan$2.1MMayJunJulAug 2026: $127K under a disclosed planAug 2026: $286K to cover taxesAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Edgewise Therapeutics, Inc. (EWTX)CMOMay 4, 2021Aug 17, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.